Charcot-Marie-Tooth Association
Historical collection: May 2019 · Rating details mostly from 2017. Source & context
What this organization describes
Seeking a cure for CMT while improving the quality of life for those affected by it
Mission and tagline reproduced from the source record.
Three perspectives. One record.
out of 100
out of 100
out of 100
These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗
Revenue, expenses, and composition
Program expenses
$2,130,797.39 recorded amountFundraising expenses
$297,143.38 recorded amountAdministrative expenses
$109,206.54 recorded amount- Fundraising efficiency
- $0.19 spent per $1 raised in donations, as defined in the source.
Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗
The leadership information supplied
- Recorded leader
- Amy Gray
- Recorded compensation
- $152,692.00
- Recorded compensation percentage
- 6.01%
These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗
Inspect all 23 original source fields
Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.
| Source field | Original source value |
|---|---|
ascoreAccountability & transparency score | 100.0 |
categoryCategory | Health |
descriptionMission & description | The Charcot-Marie-Tooth Association (CMTA) was founded in 1983 to generate the resources to find a cure for CMT, a genetic neurological disorder that affects some 2.8 million people of all races and ethnic groups worldwide. The disease kills the long nerves to the feet and hands. As the nerves to the extremities weaken and die, the muscles around them atrophy and patients lose normal use of their feet, legs, hands and arms. In fulfillment of its mission, the CMTA funds a multifaceted research program called the Strategy to Accelerate Research, which brings together the world's leading CMT researchers to collaborate with the National Institutes of Health, universities, and pharmaceutical, biotechnology, and research service companies in partnerships that are driving progress toward treatments and cures for CMT. While the CMTA searches for a cure, it also creates awareness about this orphan disease and works to improve the quality of life of all those affected by it. |
einEIN | 22-2480896 |
tot_expTotal expenses | 2539687.0 |
admin_exp_pAdministrative expense fraction | 0.043 |
fund_effFundraising efficiency ($ per $1 raised) | 0.19 |
fund_exp_pFundraising expense fraction | 0.11699999999999999 |
program_exp_pProgram expense fraction | 0.8390000000000001 |
fscoreFinancial score | 82.18 |
leaderRecorded leader | Amy Gray |
leader_compRecorded leader compensation | 152692.0 |
leader_comp_pRecorded leader compensation fraction | 0.0601 |
mottoTagline | Seeking a cure for CMT while improving the quality of life for those affected by it |
nameCharity name | Charcot-Marie-Tooth Association |
tot_revTotal revenue | 3138829.0 |
scoreOverall score | 87.39 |
stateState code | PA |
subcategorySubcategory | Diseases, Disorders, and Disciplines |
sizeSource size label | small |
program_expProgram expenses | 2130797.393 |
fund_expFundraising expenses | 297143.37899999996 |
admin_expAdministrative expenses | 109206.541 |
Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.